The treatment of blood components with ultraviolet-B irradiation.
Pamphilon
D H
DH
Institute for Transfusion Sciences, National Blood Service-Bristol Centre, UK. derwood.pamphilon@nbs.nhs.uk
D000818:Animals; D001769:Blood / Q000528:radiation effects*; D016913:Blood Component Transfusion / Q000009:adverse effects / Q000379:methods*; D001792:Blood Platelets / Q000276:immunology / Q000528:radiation effects; D004249:DNA Damage; D004285:Dogs; D006680:HLA Antigens / Q000276:immunology*; D006648:Histocompatibility; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007518:Isoantibodies / Q000096:biosynthesis; D017708:Leukocyte Transfusion; D007962:Leukocytes / Q000276:immunology / Q000528:radiation effects; D008213:Lymphocyte Activation / Q000528:radiation effects*; D017713:Platelet Transfusion; D011829:Radiation Dosage; D012449:Safety; D013242:Sterilization; D014466:Ultraviolet Rays; D014780:Viruses / Q000528:radiation effects
D006680:HLA Antigens; D007518:Isoantibodies